Work

A phase I/IB study of ipatasertib in combination with carboplatin or carboplatin/paclitaxel or capecitabine and atezolizumab in patients with metastatic triple-negative breast cancer.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.1078

Authors: Yuan Yuan, Susan Elaine Yost, Paul Henry Frankel, Christopher Ruel, Mireya Murga, Aileen Tang, Norma Martinez, James Ross Waisman, Daphne B. Stewart, Niki Himat Patel, Joanne E. Mortimer

Institution: City Of Hope National Medical Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: City of Hope

OpenAlex ID: W3172758895

Cites:

Cited by: 2

Related to: 10